Immediate hypersensitivity reaction following liposomal amphotericin-B (AmBisome) infusion
Liposomal amphotericin-B (AmBisome) is now becoming first choice for the treatment of visceral leishmaniasis (kala-azar) patients due to high efficacy and less toxicity. The reported incidence of hypersensitivity reactions to liposomal amphotericin-B (AmBisome), especially during therapy, is very ra...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
SAGE Publications
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232346/ |